Pharmacological and behavioural effects of tryptamines present in psilocybin‐containing mushrooms
British Journal of Pharmacology2024Vol. 181(19), pp. 3627–3641
Citations Over TimeTop 10% of 2024 papers
Ryan J. Rakoczy, Grace N. Runge, Abhishek K. Sen, Oscar Sandoval, Hunter G. Wells, Quynh Nguyen, B. Roberts, Jon H. Sciortino, William E. Gibbons, Lucas M. Friedberg, J. Andrew Jones, Matthew S. McMurray
Abstract
Collectively, this work suggests that other naturally occurring tryptamines, especially norbaeocystin, may share overlapping therapeutic potential with psilocybin, but without causing hallucinations.
Related Papers
- → Pharmacological and behavioural effects of tryptamines present in psilocybin‐containing mushrooms(2024)17 cited
- → Observations concerning the synthesis of tryptamine homologues and branched tryptamine derivatives via the borrowing hydrogen process: synthesis of psilocin, bufotenin, and serotonin(2016)33 cited
- → Hallucinogenic Mushrooms(2019)8 cited
- → Psychedelics and Hallucinogens in Psychiatry: Finding New PharmacologicalTargets(2021)6 cited
- → Pharmacological and behavioral effects of tryptamines present in psilocybin-containing mushrooms(2023)2 cited